Trials / Unknown
UnknownNCT06269731
Anxiety & Depression in Thyroid Cancer Patients
Anxiety, Depression and Quality of Life in Thyroid Cancer Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 159 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- —
Summary
1. To identify the prevalence of both anxiety and depression in thyroid cancer patients 2. To assess quality of life in thyroid cancer patients
Detailed description
In recent years, increasing attention has been paid to mental health among cancer patients. Thyroid cancer is one of the most frequent endocrine neoplasia. It consists of 4 subtypes of papillary thyroid cancer, follicular thyroid cancer, medullary thyroid cancer, and anaplastic thyroid cancer. Which is usually asymptomatic in the early stages, but symptoms such as neck pain, hoarseness, and dysphagia may occur as the disease progresses. TC is diagnosed by physical examination, analysis of thyroid hormone levels, imaging, and biopsy. Anxiety and depression are the most common psychological problems in the treatment of cancer patients and are related to the majority of medical diseases and physical symptoms. Studies have suggested that anxiety and depression are common in patients with thyroid cancer. Therefore, quality of life which includes psychological, social, and spiritual well-being, has become an important consideration . These findings highlight the importance of identifying thyroid cancer patients needs to allow better and more adequate care and support.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Hamilton depression Rating Scale | also known as the Ham-D is the most widely used clinician-administered depression assessment scale. The original version contains 17 items (HDRS17) pertaining to symptoms of depression experienced over the past week. Although the scale was designed for completion after an unstructured clinical interview, The scale has been translated into a number of languages including French, German, Italian, Thai , Turkish and Arabic version by Mostafa Lotfy. |
Timeline
- Start date
- 2024-03-01
- Primary completion
- 2025-12-01
- Completion
- 2026-03-01
- First posted
- 2024-02-21
- Last updated
- 2024-02-21
Source: ClinicalTrials.gov record NCT06269731. Inclusion in this directory is not an endorsement.